МЕТАФОРА - SR

Przegląd produktu

About METAFORA - SR

Metformn - this biguanid with antygipergmedicineemichnym effect, which reduces blood glucose level in plazmi blood as fasting, tak and after intake food.

Medicine is intended for the treatment of diabetes mellitus 2-go type in adults and children from 10 years of age.

Metformn acts three shliakhamy: reduces production glucose in pechinthese, improves chutlyvist to insulin in m'iazakh and zatrymuie vsmoktuvannia glucose in intestine.

Composition

Excipients: povidone, magnesium stearate, aboutolonka: sumish for plivkovogo pokryttia Opadry Clear: giaboutmeloza, polietylengmedicineol.

Metformn - 1000 mg.

Indications

Tsukrovyi diabet 2-go type in noteffectivelysti actstotherapy and rezhymu fizychnykh navantazhen, especially in khvorykh with excess weight body.

Medicine is used as monotherapy or kombinovana therapy sumisno with other peroralnymy hypoglycaemic agents or sumisno with insulin for treatment adults.

Dlia reduction complications diabetes mellitus in adults patients iz tsukrovym diabetom 2-go type and excess weight body as medicine first line after noteffective actstotherapy.

Pharmacological properties

Mechanism of action. Metformn reduces blood glucose level in plazmi blood by inhibition gliukonotogenotzu and gmedicineogenolizu in pechinthese.

Medicine also improves chutlyvist to insulin in m'iazakh, that leads to polipshennia peryferychnogo zakhoplennia and utylizathesei glucose.

Metformn stimulates vnutrishnocellsnyi synthesis gmedicineogenu and zpainshuie twoundssportnu zdibnist usikh vidomykh typiv membranesnykh perenosnykiv glucose (GLUT).

Source: Compendium